Breaking News Instant updates and real-time market news.

FIVN

Five9

$62.71

-2.03 (-3.14%)

, CRM

Salesforce

$162.45

-0.28 (-0.17%)

11:15
11/19/19
11/19
11:15
11/19/19
11:15

Canaccord says 'stay the course' with Five9 after Salesforce Cloud Voice reveal

Canaccord analyst David Hynes Jr. noted that Salesforce (CRM) revealed Service Cloud Voice, which is expected to be in pilot by February 2020 and generally available in June 2020, at its Dreamforce event. While it's unclear at this point what impact, if any, this could have on Salesforce's enterprise referral relationship with Five9 (FIVN) and he is not surprised to see the latter trading modestly lower today, Hynes Jr. recommends investors "stay the course" with Five9. To support his call for patience, Hynes Jr. stated that Five9 is "undeniably a leader" in delivering integrated telephony capabilities in the cloud, said that Salesforce's chosen out-of-the-box telephony partner, Amazon Connect, has "proven to date to have had little traction in enterprise markets," and argued that similar announcements from Five9 partners in the past - such as Zendesk Talk powered by Twilio - have had little impact on Five9's enterprise momentum. He keeps a Buy rating and $70 price target on Five9 shares, which are down 3% to $62.76 at time of writing.

FIVN

Five9

$62.71

-2.03 (-3.14%)

CRM

Salesforce

$162.45

-0.28 (-0.17%)

AMZN

Amazon.com

$1,745.27

-7.43 (-0.42%)

ZEN

Zendesk

$77.20

(0.00%)

TWLO

Twilio

$101.30

-0.355 (-0.35%)

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

  • 20

    Nov

  • 21

    Nov

  • 03

    Dec

  • 09

    Dec

  • 11

    Dec

  • 16

    Dec

  • 17

    Dec

FIVN Five9
$62.71

-2.03 (-3.14%)

11/13/19
11/13/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. G-III Apparel (GIII) upgraded to Buy from Neutral at BofA/Merrill with analyst Heather Balsky saying she anticipates the company to benefit from a likely accelerated wind-down of unprofitable outlet business and derisking with regards to tariffs. 2. Rockwell Automation (ROK) upgraded to Neutral from Underperform at Credit Suisse with analyst John Walsh saying he is upgrading shares based on his view that Industrial Production recovers in 2H20, achievable EPS growth in FY20 driven by restructuring on flat organic sales and a more balanced risk/reward valuation profile. 3. Infinera (INFN) upgraded to Neutral from Underweight at JPMorgan with analyst Samik Chatterjee saying she believes Infinera's recent Coriant acquisition execution is going to make investors more willing to "position themselves for the upside" from the company achieving profitability metrics similar to larger competitor Ciena (CIEN). 4. Freeport McMoRan (FCX) upgraded to Buy from Neutral at BofA/Merrill with analyst Timna Tanners saying she is looking past the company's "transition year" and expects its Grasberg asset to make a full contribution for copper and gold production. 5. Five9 (FIVN) upgraded to Buy from Neutral at Rosenblatt with analyst Ryan Koontz saying he came away from the company's analyst event "thoroughly impressed." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/13/19
RSBL
11/13/19
UPGRADE
Target $75
RSBL
Buy
Rosenblatt 'thoroughly impressed' by Five9 meeting, upgrades to Buy afterward
As previously reported, Rosenblatt analyst Ryan Koontz upgraded Five9 (FIVN) to Buy from Neutral with a price target of $75, up from $66, after coming away from the company's analyst event "thoroughly impressed." During the meeting, CEO Rowan Trollope articulated the company's "strong market position and vast market opportunity," said Koontz, who expresses confidence that both the company and key competitor NICE (NICE) are likely to see continued success ahead of a multi-year cycle. He also sees "downside protection" for Five9 shares given what he views as an acquisition premium in the stock.
11/13/19
RSBL
11/13/19
UPGRADE
Target $75
RSBL
Buy
Five9 upgraded to Buy from Neutral at Rosenblatt
Rosenblatt analyst Ryan Koontz upgraded Five9 to Buy from Neutral with a $75 price target.
11/06/19
CHLM
11/06/19
NO CHANGE
Target $72
CHLM
Buy
Five9 price target raised to $72 from $68 at Craig-Hallum
Craig-Hallum analyst Jeff Van Rhee raised his price target for Five9 to $72 from $68 and maintained a Buy rating following the company's "strong" quarter and guidance. In a research note to investors, Van Rhee says that with only 10%-15% cloud penetration and a team that again noted they see "many years of 30's level enterprise growth ahead," he believes the runway for sustainable high growth is very long.
CRM Salesforce
$162.45

-0.28 (-0.17%)

11/13/19
PIPR
11/13/19
INITIATION
Target $190
PIPR
Overweight
Salesforce assumed with an Overweight at Piper Jaffray
Piper Jaffray analyst Brent Bracelin assumed coverage of Salesforce with an Overweight rating and $190 price target. The analyst sees a favorable risk/reward ahead of Q4 seasonality and given the company's $10 per share share in free cash flow power.
11/18/19
COWN
11/18/19
NO CHANGE
Target $185
COWN
Outperform
Salesforce remains a top pick ahead of Dreamforce, says Cowen
Cowen analyst J. Derrick Wood said Salesforce (CRM) remains a top pick ahead of is Dreamforce show and subsequent analyst day. The analyst expects a normal show with nothing too incremental but he sees three things that could be positive catalysts; an update to revenue guidance, more details around its Tableau (DATA) acquisition, and color around its Microsoft (MSFT) partnership that was announced last week. Wood reiterated his Outperform rating and $185 price target on Salesforce shares.
11/18/19
BMOC
11/18/19
NO CHANGE
Target $188
BMOC
Outperform
BMO Capital sees 'upside tension' for Salesforce margins ahead of Dreamforce
BMO Capital analyst Keith Bachman is keeping his Outperform rating and $188 price target on Salesforce going into Dreamforce and the related analyst events taking place this week. The analyst believes that there is "upside tension" to consensus operating margin estimates for the company and expects the management to highlight its future margin opportunities. While Salesforce's underlying business is doing "very well", Bachman notes that the management's acquisition trends are keeping the company's consolidated margins from expanding.
11/18/19
JEFF
11/18/19
NO CHANGE
Target $195
JEFF
Buy
Salesforce price target raised to $195 ahead of Dreamforce at Jefferies
Jefferies analyst Brent Thill said his survey of 53 Salesforce partners ahead of the company's Dreamforce event was "generally positive" and he believes expectations for Q3 and FY20 seem reasonable while the the risk-reward for the stock is favorable at current levels. He expects the company to give long-term guidance updates at Dreamforce and would not be surprised if Salesforce chose to pre-announce revenue and EPS ahead of the Investor Day next week, Thill said. Adding that he thinks the pipeline "remains robust," Thill keeps a Buy rating on Salesforce and raised his price target on the stock to $195 from $171.
AMZN Amazon.com
$1,745.27

-7.43 (-0.42%)

11/13/19
NOMU
11/13/19
NO CHANGE
Target $42
NOMU
Neutral
Nike ending direct Amazon sales positive for Dick's, says Nomura Instinet
Nomura Instinet analyst Michael Baker says Nike's (NKE) decision to stop selling product directly to Amazon (AMZN), as reported this morning by Bloomberg, should be positive for Dick's Sporting Goods (DKS). Nike product will still be available on Amazon through its third-party market place, so the good for Dick's "is only modest," Baker tells investors in a research note titled "DKS Winning Online." The analyst believes Dick's is one of Nike's most valuable partners. The company accounts for about 6.6% of Nike's North American sales and 9.6% of its North American wholesale sales, and the penetration has been growing, contends Baker. This makes Dick's Nike's second-biggest wholesale partner, says the analyst, how keeps a Neutral rating on Dick's with a $42 price target.
11/15/19
JPMS
11/15/19
NO CHANGE
JPMS
Overweight
JPMorgan adds Lyft to list of top Internet picks
Earlier, JPMorgan analyst Doug Anmuth added Lyft (LYFT) to his list of top picks in the internet sector following third quarter earnings, saying the ride-hailing giant reported "significantly" better than expected revenue and EBITDA as it continues to take share of an increasingly rational U.S. rideshare market, thereby accelerating its path to profitability. Anmuth said that Lyft, which joins Facebook (FB), Amazon (AMZN), and Netflix (NFLX) in his top picks in the sector, also reiterated its expectation for consolidated EBITDA profit by the fourth quarter of 2021, though he continues to believe core rideshare can be profitable "well before that," likely sometime in 2020. The analyst, who has an Overweight rating on Lyft, noted that he removed Twitter (TWTR) and IAC/InterActive (IAC) from his top picks.
11/18/19
DADA
11/18/19
INITIATION
Target $55
DADA
Neutral
Crowdstrike valuation appropriately balances upside potential, says DA Davidson
As reported earlier, DA Davidson Andrew Nowinski initiated coverage of Crowdstrike (CRWD) with a Neutral rating and $55 price target, saying the company is generating "unmatched" ARR growth, driven by sustainable, competitive advantages from a cloud-based platform. Nowinski said he believes the Amazon Web services (AMZN) partnership is seeing increasing momentum and the company has the potential to expand margins longer-term. The analyst noted, however, that he believes the current valuation appropriately balances the upside potential from these drivers.
11/19/19
WBLR
11/19/19
NO CHANGE
WBLR
Outperform
Kornit sales beat when adjusting for Amazon warrants, says William Blair
William Blair analyst Brian Drab says Kornit Digital (KRNT) reported "another impressive quarter." Kornit's Q3 results were ahead of expectations, contrary to the negative headlines immediately following the report, which were again based on misinterpretation of results given the impact of Amazon warrants (AMZN), Drab tells investors in a post-earnings research note. Adjusting correctly for the warrants, the company's Q3 revenue increased 27%, to $49.7M, ahead of the consensus estimate of $48.7M, adds the analyst. He expects Kornit to continue to generate greater than 20% revenue growth and keeps an Outperform rating on the shares.
ZEN Zendesk
$77.20

(0.00%)

10/30/19
WEDB
10/30/19
NO CHANGE
Target $82
WEDB
Outperform
Zendesk price target lowered to $82 from $98 at Wedbush
Wedbush analyst Steve Koenig lowered his price target for Zendesk to $82 from $98 and maintained an Outperform rating, saying that the company's Q3 print and earnings call were "comforting" following a disappointing Q2. Zendesk is addressing decelerating international growth with process improvements in low-end EMEA markets and planned recruiting of top-level leadership talent, Koenig tells investors in a research note, adding that Q4 expectations look "beatable."
10/30/19
ADAM
10/30/19
NO CHANGE
Target $85
ADAM
Buy
Zendesk price target lowered to $85 from $105 at Canaccord
Canaccord analyst David Hynes lowered his price target on Zendesk to $85 from $105 following Q3 results. The analyst said the big picture remains fully intact and guidance for the full-year modestly improved but he found the quarter to be a bit of a mixed bag.He is not totally confident in the company's strategy but said the next big catalyst will be its 2020 guidance in early February. Hynes maintained his Buy rating on Zendesk shares.
10/30/19
RBCM
10/30/19
NO CHANGE
Target $81
RBCM
Outperform
Zendesk price target lowered to $81 from $100 at RBC Capital
RBC Capital analyst Alex Zukin lowered his price target on Zendesk to $81 after its "mixed" Q3 results, saying that while the company beat on revenue and margins, its billings underperformed and its net retention rate of 116% was down 1pt from Q2. The analyst still keeps his Outperform rating on Zendesk given the company's growth opportunity based on its position as a "small player in a large market" as well as its potential of being an "interesting" strategic target.
11/12/19
MSCO
11/12/19
NO CHANGE
Target $102
MSCO
Overweight
Zendesk could be set-up for strong Q4, says Morgan Stanley
Morgan Stanley analyst Stan Zlotsky said after hosting meetings with Zendesk CFO Elena Gomez and VP of Strategy Marc Cabi that management commentary on the macro environment sounded a bit more stable compared to 90 days earlier. His sense of the underlying improvements in Zendesk's macro environment, combined with what he sees as a heightened focus on execution and closing deals early, leads Zlotsky to believe that Zendesk could have a strong Q4, he tells investors. He also sees room for management to set up "beat and raise" quarters into next year, added Zlotsky, who keeps an Overweight rating and $102 price target on Zendesk shares.
TWLO Twilio
$101.30

-0.355 (-0.35%)

11/13/19
PIPR
11/13/19
NO CHANGE
Target $140
PIPR
Overweight
Twilio investors need to climb over 'wall of worry,' says Piper Jaffray
Street estimates show Twilio's total revenue growth slowing to 26.8% year-over-year by Q3 of 2020 from 74.7% last quarter based on tough comparisons within the top 10 customer cohort and anniversary of the SendGrid acquisition, Piper Jaffray analyst Brent Bracelin tells investors in a research note. This combined with the billings and earnings guidance error has shaken near-term investor sentiment, pressuring shares to fall 37% below the 52 week highs, adds the analyst. He believes investors need to get comfortable with this "wall of worry" before establishing new positions in Twilio. Bracelin, however, says his analysis shows the company's mass market still growing 50% year-over-year while SendGrid growth has accelerated slightly. He keeps an Overweight rating on Twilio with a $140 price target.
10/31/19
10/31/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Gardner Denver (GDI) downgraded to Neutral from Outperform at Credit Suisse with analyst John Walsh saying he does not see a catalyst to drive the stock higher. 2. Owens-Illinois (OI) downgraded to Market Perform from Outperform at Wells Fargo with analyst Gabe Hajde saying he was wrong as the primary tenant to his thesis, volume growth, is not materializing. 3. Cree (CREE) downgraded to Underweight from Neutral at JPMorgan with analyst Paul Coster saying the company's "lackluster" Q2 guidance underscores a lack of near-term catalysts. 4. Southwest (LUV) downgraded to Market Perform from Outperform at Bernstein with analyst David Vernon saying he thinks the market is pricing in all the good news on the return of Boeing's (BA) MAX and not appreciating how disruptive its return could be on either the unit revenue or cost fronts. 5. Twilio (TWLO) downgraded to Neutral from Buy at Monness Crespi with analyst Brian White calling the company's mixed Q3 results and weak Q4 outlook "the final straw in what has been a sideways year." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/31/19
DADA
10/31/19
NO CHANGE
Target $125
DADA
Buy
Twilio price target lowered to $125 from $163 at DA Davidson
DA Davidson analyst Rishi Jaluria lowered his price target on Twilio to $125 after its "mixed" Q3 results, with a "rare miss" on revenue and a light Q4 outlook. The analyst is keeping his Buy rating however, stating that absent the errors in the billings process, revenue would have exceeded expectations. Jaluria also notes that the quarter was "solid overall", with greater Flex adoption and accelerating revenue growth at its SendGrid business.
10/31/19
NEED
10/31/19
NO CHANGE
Target $125
NEED
Buy
Twilio price target lowered to $125 from $165 at Needham
Needham analyst Richard Valera lowered his price target on Twilio to $125, saying that while the company beat on Q3 earnings, its FY19 guidance cut was a "shock". The analyst notes that Twilio saw "sharp" moderations in growth over the past 2 quarters, but still keeps his Buy rating on the stock longer term given its position as a "category leader" in a multi-billion dollar market with "nascent" total addressable market expansion potential.

TODAY'S FREE FLY STORIES

AOBC

American Outdoor Brands

$9.23

-0.04 (-0.43%)

, AVCO

Avalon GloboCare

$2.27

-0.06 (-2.58%)

04:55
12/15/19
12/15
04:55
12/15/19
04:55
Conference/Events
Roth Capital to hold a conference »

8th Annual ROTH Deer…

AOBC

American Outdoor Brands

$9.23

-0.04 (-0.43%)

AVCO

Avalon GloboCare

$2.27

-0.06 (-2.58%)

BBSI

Barrett Business

$93.18

1.82 (1.99%)

BNGO

Bionano Genomics

$1.02

0.01 (0.99%)

IRMD

iRadimed

$25.25

-0.52 (-2.02%)

FC

Franklin Covey

$35.21

-0.57 (-1.59%)

NBEV

New Age Beverages

$1.91

-0.015 (-0.78%)

WATT

Energous

$1.99

(0.00%)

EAST

Eastside Distilling

$2.79

-0.12 (-4.12%)

DCTH

Delcath Systems

$0.00

(0.00%)

BOOM

DMC Global

$52.89

0.64 (1.22%)

CLAR

Clarus

$13.47

-0.02 (-0.15%)

JRSH

Jerash Holdings

$6.46

(0.00%)

MCHX

Marchex

$3.68

0.03 (0.82%)

JYNT

Joint Corp.

$17.37

0.28 (1.64%)

SOLY

Soliton

$10.35

-0.005 (-0.05%)

SMSI

Smith Micro

$4.66

0.095 (2.08%)

PWFL

PowerFleet

$6.10

0.05 (0.83%)

OSIS

OSI Systems

$100.60

0.63 (0.63%)

LOVE

Lovesac

$10.80

-1.01 (-8.55%)

VERI

Veritone

$2.73

-0.1 (-3.53%)

WTER

Alkaline Water

$1.09

-0.01 (-0.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 19

    Dec

  • 23

    Jan

  • 23

    Jan

  • 24

    Jan

  • 29

    Jan

PNC

PNC Financial

$158.60

-0.3 (-0.19%)

, PYPL

PayPal

$107.68

2.01 (1.90%)

13:57
12/14/19
12/14
13:57
12/14/19
13:57
Periodicals
PNC clients having trouble connecting to PayPal's Venmo, WSJ reports »

Many of PNC…

PNC

PNC Financial

$158.60

-0.3 (-0.19%)

PYPL

PayPal

$107.68

2.01 (1.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

  • 15

    Jan

BRK.A

Berkshire Hathaway

$338,250.51

-992.49 (-0.29%)

, CMCSA

Comcast

$43.59

0.57 (1.33%)

07:44
12/14/19
12/14
07:44
12/14/19
07:44
Periodicals
Berkshire, Anthem among Barron's top 10 stock picks for 2020 »

Barron's has…

BRK.A

Berkshire Hathaway

$338,250.51

-992.49 (-0.29%)

CMCSA

Comcast

$43.59

0.57 (1.33%)

RDS.B

Royal Dutch Shell

$57.41

-0.19 (-0.33%)

RDS.A

Royal Dutch Shell

$57.44

-0.32 (-0.55%)

PFE

Pfizer

$38.31

-0.23 (-0.60%)

VIAC

ViacomCBS

$38.62

0.83 (2.20%)

ANTM

Anthem

$284.14

-0.405 (-0.14%)

DELL

Dell Technologies

$49.39

-0.11 (-0.22%)

GOOG

Alphabet

$1,348.07

-2.09 (-0.15%)

GOOGL

Alphabet Class A

$1,347.11

-1.4 (-0.10%)

UHAL

Amerco

$360.28

7.57 (2.15%)

UTX

United Technologies

$148.99

-0.5 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 27

    Feb

PCG

PG&E

$11.26

-0.49 (-4.17%)

07:38
12/14/19
12/14
07:38
12/14/19
07:38
Hot Stocks
California Governor says PG&E restructuring plan 'falls woefully short' »

California Governor Gavin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

MYGN

Myriad Genetics

$25.58

0.58 (2.32%)

07:31
12/14/19
12/14
07:31
12/14/19
07:31
Hot Stocks
Myriad Genetics says study validates polygenic risk score for breast cancer »

Myriad Genetics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TPC

Tutor Perini

$15.73

-0.17 (-1.07%)

07:30
12/14/19
12/14
07:30
12/14/19
07:30
Hot Stocks
Tutor Perini 'disappointed,' will appeal jury verdict in SR 99 Alaskan Way case »

Tutor Perini released a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLRX

BioLineRx

$2.38

-0.23 (-8.81%)

, BD

Budget Group

$0.00

(0.00%)

04:55
12/14/19
12/14
04:55
12/14/19
04:55
Conference/Events
European Society for Medical Oncology to hold a conference »

ESMO Immuno-Oncology…

BLRX

BioLineRx

$2.38

-0.23 (-8.81%)

BD

Budget Group

$0.00

(0.00%)

IDRA

Idera Pharmaceuticals

$1.59

-0.05 (-3.05%)

MRK

Merck

$89.18

0.84 (0.95%)

PFE

Pfizer

$38.31

-0.23 (-0.60%)

NKTR

Nektar

$21.28

-0.53 (-2.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 24

    Jan

  • 24

    Jan

  • 05

    Feb

  • 14

    Mar

ATNX

Athenex

$14.56

-2.38 (-14.05%)

, MRK

Merck

$89.18

0.84 (0.95%)

04:55
12/14/19
12/14
04:55
12/14/19
04:55
Conference/Events
Society of Surgical Oncology to hold a symposium »

San Antonio Breast Cancer…

ATNX

Athenex

$14.56

-2.38 (-14.05%)

MRK

Merck

$89.18

0.84 (0.95%)

ONCS

OncoSec

$2.00

-0.39 (-16.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 24

    Jan

  • 24

    Jan

  • 05

    Feb

  • 14

    Mar

ACB

Aurora Cannabis

$2.63

0.02 (0.77%)

, CRON

Cronos Group

$7.28

-0.03 (-0.41%)

04:55
12/14/19
12/14
04:55
12/14/19
04:55
Conference/Events
MJBizDaily to hold a conference »

Marijuana Business…

ACB

Aurora Cannabis

$2.63

0.02 (0.77%)

CRON

Cronos Group

$7.28

-0.03 (-0.41%)

NFX

Newfield Exploration

$0.00

(0.00%)

CGC

Canopy Growth

$20.69

-0.455 (-2.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDSI

BioDelivery Sciences

$6.40

-0.065 (-1.01%)

04:55
12/14/19
12/14
04:55
12/14/19
04:55
Conference/Events
BioDelivery Sciences management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

AOBC

American Outdoor Brands

$9.23

-0.04 (-0.43%)

, AVCO

Avalon GloboCare

$2.27

-0.06 (-2.58%)

04:55
12/14/19
12/14
04:55
12/14/19
04:55
Conference/Events
Roth Capital to hold a conference »

8th Annual ROTH Deer…

AOBC

American Outdoor Brands

$9.23

-0.04 (-0.43%)

AVCO

Avalon GloboCare

$2.27

-0.06 (-2.58%)

BBSI

Barrett Business

$93.18

1.82 (1.99%)

BNGO

Bionano Genomics

$1.02

0.01 (0.99%)

IRMD

iRadimed

$25.25

-0.52 (-2.02%)

FC

Franklin Covey

$35.21

-0.57 (-1.59%)

NBEV

New Age Beverages

$1.91

-0.015 (-0.78%)

WATT

Energous

$1.99

(0.00%)

EAST

Eastside Distilling

$2.79

-0.12 (-4.12%)

DCTH

Delcath Systems

$0.00

(0.00%)

BOOM

DMC Global

$52.89

0.64 (1.22%)

CLAR

Clarus

$13.47

-0.02 (-0.15%)

JRSH

Jerash Holdings

$6.46

(0.00%)

MCHX

Marchex

$3.68

0.03 (0.82%)

JYNT

Joint Corp.

$17.37

0.28 (1.64%)

SOLY

Soliton

$10.35

-0.005 (-0.05%)

SMSI

Smith Micro

$4.66

0.095 (2.08%)

PWFL

PowerFleet

$6.10

0.05 (0.83%)

OSIS

OSI Systems

$100.60

0.63 (0.63%)

LOVE

Lovesac

$10.80

-1.01 (-8.55%)

VERI

Veritone

$2.73

-0.1 (-3.53%)

WTER

Alkaline Water

$1.09

-0.01 (-0.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Dec

  • 19

    Dec

  • 23

    Jan

  • 23

    Jan

  • 24

    Jan

  • 29

    Jan

WFT

Weatherford

$0.00

(0.00%)

18:49
12/13/19
12/13
18:49
12/13/19
18:49
Hot Stocks
Weatherford completes financial restructuring, emerges from Chapter 11 »

Weatherford announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$57.71

-0.81 (-1.38%)

18:40
12/13/19
12/13
18:40
12/13/19
18:40
Hot Stocks
Centene CEO: Our big markets are growing, we're gaining share »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

LYV

Live Nation

$64.24

-5.205 (-7.50%)

, ZBRA

Zebra Technologies

$257.82

-0.32 (-0.12%)

18:29
12/13/19
12/13
18:29
12/13/19
18:29
Hot Stocks
S&P announces changes to S&P 400, 500, 600 indices »

S&P Dow Jones Indices…

LYV

Live Nation

$64.24

-5.205 (-7.50%)

ZBRA

Zebra Technologies

$257.82

-0.32 (-0.12%)

STE

Steris

$151.93

-1.745 (-1.14%)

AMG

Affiliated Managers

$85.18

-1.77 (-2.04%)

TRIP

TripAdvisor

$29.24

-0.2 (-0.68%)

MAC

Macerich

$26.04

-0.46 (-1.74%)

LOPE

Grand Canyon

$89.24

-0.86 (-0.95%)

LEA

Lear

$129.43

-0.84 (-0.64%)

OAS

Oasis Petroleum

$2.68

-0.295 (-9.93%)

SWN

Southwestern Energy

$2.00

-0.12 (-5.66%)

UNT

Unit Corp.

$0.83

-0.0626 (-6.98%)

FTR

Frontier Communications

$0.68

0.0315 (4.84%)

ARWR

Arrowhead

$66.47

-0.91 (-1.35%)

GVA

Granite Construction

$26.21

-1.335 (-4.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 23

    Mar

PLAN

Anaplan

$51.80

1.44 (2.86%)

18:23
12/13/19
12/13
18:23
12/13/19
18:23
Hot Stocks
Anaplan CEO: Digitization has really started to accelerate »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WPX

WPX Energy

$10.92

-0.24 (-2.15%)

18:08
12/13/19
12/13
18:08
12/13/19
18:08
Periodicals
WPX Energy in talks to acquire Felix Energy assets for $2.5B, Bloomberg says »

WPX Energy is in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

HLIT

Harmonic

$7.94

-0.25 (-3.05%)

17:47
12/13/19
12/13
17:47
12/13/19
17:47
Hot Stocks
Harmonic CFO sells 28K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HZNP

Horizon Pharma

$32.84

(0.00%)

17:36
12/13/19
12/13
17:36
12/13/19
17:36
Hot Stocks
Breaking Hot Stocks news story on Horizon Pharma »

Horizon Pharma up 9.6% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 08

    Mar

AMRN

Amarin

$24.12

1.12 (4.87%)

17:33
12/13/19
12/13
17:33
12/13/19
17:33
Hot Stocks
Breaking Hot Stocks news story on Amarin »

Amarin rises 1.4% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

THMO

ThermoGenesis

$2.88

(0.00%)

17:31
12/13/19
12/13
17:31
12/13/19
17:31
Syndicate
Breaking Syndicate news story on ThermoGenesis »

ThermoGenesis files $30M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$24.12

1.12 (4.87%)

17:30
12/13/19
12/13
17:30
12/13/19
17:30
Hot Stocks
Breaking Hot Stocks news story on Amarin 

Amarin trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

QTNT

Quotient

$8.60

-0.165 (-1.88%)

17:28
12/13/19
12/13
17:28
12/13/19
17:28
Syndicate
Breaking Syndicate news story on Quotient »

Quotient files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARWR

Arrowhead

$66.47

-0.91 (-1.35%)

, GVA

Granite Construction

$26.21

-1.335 (-4.85%)

17:27
12/13/19
12/13
17:27
12/13/19
17:27
Hot Stocks
Breaking Hot Stocks news story on Arrowhead, Granite Construction »

Arrowhead to replace…

ARWR

Arrowhead

$66.47

-0.91 (-1.35%)

GVA

Granite Construction

$26.21

-1.335 (-4.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OAS

Oasis Petroleum

$2.68

-0.295 (-9.93%)

, SWN

Southwestern Energy

$2.00

-0.12 (-5.66%)

17:25
12/13/19
12/13
17:25
12/13/19
17:25
Hot Stocks
Oasis, Southwestern to replace Unit Corp., Frontier in S&P 600 at open on 12/23 »

Oasis Petroleum (OAS) and…

OAS

Oasis Petroleum

$2.68

-0.295 (-9.93%)

SWN

Southwestern Energy

$2.00

-0.12 (-5.66%)

UNT

Unit Corp.

$0.83

-0.0626 (-6.98%)

FTR

Frontier Communications

$0.68

0.0315 (4.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Mar

AMRN

Amarin

$24.12

1.12 (4.87%)

17:24
12/13/19
12/13
17:24
12/13/19
17:24
Hot Stocks
Amarin raises guidance after FDA approves Vascepa »

Amarin (AMRN) shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.